Iovance Biotherapeutics: Wells Fargo raises target price to $18 from $14
IOVA•Wells Fargo raised its target price for Iovance Biotherapeutics to $18 from $14.
Related News
Yuyu Pharma CEO attends Amazon Accelerate 2026 in Seattle
AMZN•
US second-quarter GDP revised higher as consumer spending remains robust
SPY•
Canada stocks: TSX opens higher as soft US inflation data dims Fed rate-hike bets
TLT•
Rent the Runway launches $15 million share rights offering at $3.55 per share
RENT•
RedCloud net loss narrows 30% to $18.5 million as revenue rises 34%
RCT•